Nashville, TN4 Active Studies

Sarcoma Soft Tissue Clinical Trials in Nashville, TN

Find 4 actively recruiting sarcoma soft tissue clinical trials in Nashville, TN. Connect with local research sites and explore new treatment options.

4
Active Trials
3
Sponsors
415
Enrolling

Recruiting Sarcoma Soft Tissue Studies in Nashville

About Sarcoma Soft Tissue Clinical Trials in Nashville

Soft tissue sarcomas are rare cancers that develop in the soft tissues of the body including muscle, fat, blood vessels, and tendons. There are more than 50 subtypes, each with different characteristics. Treatment includes surgery, radiation, and chemotherapy, with newer targeted therapies under investigation.

There are currently 4 sarcoma soft tissue clinical trials recruiting participants in Nashville, TN. These studies are seeking a combined 415 participants. Research is being sponsored by University of Michigan Rogel Cancer Center, Chimeric Therapeutics, Vanderbilt-Ingram Cancer Center. Clinical trial participation is free and participants receive study-related medical care at no cost.

Sarcoma Soft Tissue Clinical Trials in Nashville — FAQ

Are there sarcoma soft tissue clinical trials in Nashville?

Yes, there are 4 sarcoma soft tissue clinical trials currently recruiting in Nashville, TN. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Nashville?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Nashville research site will contact you about next steps.

Are clinical trials in Nashville free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Nashville studies also compensate for your time and travel.

What sarcoma soft tissue treatments are being tested?

The 4 active trials in Nashville are testing new therapies including novel drugs, biologics, and treatment approaches for sarcoma soft tissue.

Data updated October 15, 2026 from ClinicalTrials.gov